Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
ETF IssuersL&GDOCG
DOCG

L&G Healthcare Technology & Innovation UCITS ETF

The DOCG Exchange Traded Fund (ETF) is provided by L&G. It is built to track an index: ROBO Global Healthcare Technology and Innovation. The DOCG ETF provides physical exposure, so by buying it you actually own parts of all the 62 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

£1,185.60
+£1.2 (+0.10%) 2 days ago
7:00 AM 07/24/26 Closed
1D price range
£1,180.26£1,196.64
52W price range
£11.61£16.30
YTD Perf.
+6.06%
YTD Flows
Annualized volatility
Fund AuM
€241M
Share class AuM
€241M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE00BK5BC677
TER
0.49%
Inception date
7/2/2019
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 24, 2026
-10%-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
94.53%
Consumer Non-Cyclicals
2.26%
Business Services
1.63%
Industrials
1.56%
Latest DOCG news

No content available for this fund

FAQ about DOCG

DOCG is a Passive ETF. This ETF provides exposure to Other Equities.
DOCG tracks the ROBO Global Healthcare Technology and Innovation TR Index - USD, through a full replication replication method.
DOCG carries a total expense ratio (TER) of 0.49%, indicating the annual cost for holding the fund.
DOCG was introduced to the market on July 2, 2019. It trades on Netherlands, among other exchanges
L&G Healthcare Technology & Innovation UCITS ETF, DOCG, is provided by L&G. Learn more about L&G here.
DOCG oversees €241M in assets as of July 24, 2026.
DOCG follows a capitalizing, meaning it reinvests income within the fund.
As of June 30, 2026, DOCG has significant geographic allocations in USA, Switzerland and United Kingdom.
As of June 30, 2026, DOCG focuses largely on Healthcare, Consumer Non-Cyclicals and Business Services.
As of June 30, 2026, DOCG holds 62 positions in its portfolio, with 30.37% of assets concentrated in its top 15 holdings.
As of June 30, 2026, DOCG top three holdings include Twist Bioscience Corp., Natera, Inc. and Guardant Health, Inc..
The base currency of DOCG is USD.
Data as of 06/30/26
Twist Bioscience Corp.
2.46%
Natera, Inc.
2.27%
Guardant Health, Inc.
2.13%
Tempus AI, Inc.
2.12%
Arrowhead Pharmaceuticals, Inc.
2.03%
Vertex Pharmaceuticals, Inc.
2.01%
Thermo Fisher Scientific, Inc.
2.00%
Medpace Holdings, Inc.
1.99%
Adaptive Biotechnologies Corp.
1.97%
LivaNova Plc
1.97%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight